Page last updated: 2024-09-03

27-hydroxycholesterol and Bone Loss, Osteoclastic

27-hydroxycholesterol has been researched along with Bone Loss, Osteoclastic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdo, J; DuSell, CD; Gesty-Palmer, D; Javitt, NB; Khosla, S; McDonnell, DP; Mödder, UI; Nelson, ER; Umetani, M; Wang, X1
DuSell, CD; Evans, G; Gesty-Palmer, D; Howe, MK; Khosla, S; McDonnell, DP; Michalek, RD; Nelson, ER; Rathmell, JC; Umetani, M; Wang, X1

Other Studies

2 other study(ies) available for 27-hydroxycholesterol and Bone Loss, Osteoclastic

ArticleYear
The endogenous selective estrogen receptor modulator 27-hydroxycholesterol is a negative regulator of bone homeostasis.
    Endocrinology, 2010, Volume: 151, Issue:8

    Topics: Animals; Bone and Bones; Bone Density; Bone Resorption; Cholestanetriol 26-Monooxygenase; Cytochrome P450 Family 7; Estradiol; Female; Homeostasis; Hydroxycholesterols; Mice; Mice, Knockout; Osteoblasts; Osteogenesis; Selective Estrogen Receptor Modulators; Steroid Hydroxylases

2010
The oxysterol, 27-hydroxycholesterol, links cholesterol metabolism to bone homeostasis through its actions on the estrogen and liver X receptors.
    Endocrinology, 2011, Volume: 152, Issue:12

    Topics: Animals; Bone and Bones; Bone Resorption; Cell Differentiation; Cholesterol; Homeostasis; Hydroxycholesterols; Liver X Receptors; Mice; Orphan Nuclear Receptors; Osteoblasts; Receptors, Estrogen; Receptors, Steroid; Sterols

2011